52
Participants
Start Date
October 8, 2010
Primary Completion Date
June 27, 2013
Study Completion Date
June 27, 2013
MMX Mesalamine
30 mg/kg/day of MMX Mesalamine tablets, dosed once daily for 7 days.
MMX Mesalamine
60 mg/kg/day of MMX Mesalamine tablets, dosed once daily for 7 days.
MMX Mesalamine
100 mg/kg/day of MMX Mesalamine tablets, dosed once daily for 7 days.
Royal Children's Hospital Melbourne, Parkville
University of Maryland Medical Center for Children, Baltimore
Mayo Clinic, Rochester
Arkansas Children's Hospital, Little Rock
Advanced Clinical Research Institute, Anaheim
University of California, San Francisco, San Francisco
Connecticut Children's Medical Center, Hartford
Klinika Pediatrii Gastroenterologii i Zywienia, Uniwersytecki Szpital Dzieciecy w Krakowie, Wieliczka
Klinika Gastroenterolofii Pediatrii, Instytut Centrum Zdrowia Matki Polki, Lodz
Klinika Pediatrii Dzieciecy Szpital Kliniczny im prof Antoniego Gebali, Lublin
Kliniczny Oddzial Pediatrii z Pododdzialem Neurologii Dzieciecej Szpital Wojewodzki, Rzeszów
Oddzial Gastroenterologii i Hepatologii, Instytut Pomnik-Centrum Zdrowia Dziecka, Warsaw
Univerzitna nemocnica Martin, Martin
DFNsP Banska Bystrica, Banská Bystrica
Gastroenterologicka ambulancia, Bratislava
Alder Hey Children's NHS Foundation Trust, Liverpool
Barts Health NHS Trust/Royal London Hospital, London
Somers Clinical Research Facility/Great Ormond Street Hospital, London
Southampton General Hospital, Southampton
Lead Sponsor
Shire
INDUSTRY